Table 3.
Patient basis (n=360) | Infusion basis (n=1192) | ||||||
---|---|---|---|---|---|---|---|
Adverse reaction | Adverse reaction | ||||||
No | Yes | p value | No | Yes | p value | ||
Gender, n (%) | |||||||
Male | 211 (99.1) | 2 (0.9) | 680 (99.6) | 3 (0.4) | |||
Female | 145 (98.7) | 2 (1.3) | 1.00 | 507 (99.6) | 2 (0.4) | 1.00 | |
Age, n (%) | |||||||
< 15 years | 69 (97.2) | 2 (2.8) | 181 (97.2) | 3 (1.6) | |||
≥ 15 years | 287 (99.3) | 2 (0.7) | 0.245 | 1006 (99.3) | 2 (0.2) | 0.025 | |
IVIG doses (average, g/kg BW) | 0.4† | 1.4† | 0.395 | 0.16 | 0.19 | 0.564 | |
Indication, n (%) | |||||||
Hypogammaglobulinaemia | 63 (98.4) | 1 (1.6) | 286 (99.4) | 2 (0.6) | |||
Sepsis | 293 (99.0) | 3 (1.0) | 901 (99.7) | 3 (0.3) |
*The low-dose IVIG is less than 0.7 g/kg body weight per course.
†The values indicate the cumulative doses from multiple treatment of IVIG on one patient.
BW, body weight of patient.